End-of-day quote
Other stock markets
|
||
- USD | - |
Apr. 25 | ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 24.5M |
---|---|---|---|---|---|
Net income 2022 | -9M | Net income 2023 | -5M | EV / Sales 2022 | - |
Net cash position 2022 | 42.06M | Net cash position 2023 | 37.15M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.44
x | P/E ratio 2023 |
-4.59
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.71% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Keuer
CEO | Chief Executive Officer | 65 | 06-09-30 |
C. Dekker
DFI | Director of Finance/CFO | 60 | 21-05-09 |
Sharon Perry
LAW | General Counsel | - | 07-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anders Hove
BRD | Director/Board Member | 58 | 17-02-15 |
Robert Conway
CHM | Chairman | 70 | 13-09-02 |
Linda Grais
BRD | Director/Board Member | 68 | 07-04-30 |
1st Jan change | Capi. | |
---|---|---|
+8.96% | 105B | |
-1.43% | 104B | |
+4.40% | 22.94B | |
-12.15% | 22.34B | |
-4.36% | 19.25B | |
-39.98% | 17.08B | |
-10.04% | 16.96B | |
+38.61% | 12.63B | |
+313.59% | 8.49B |